PubMed

Timely intervention for invasive fungal disease: should the road now lead to the laboratory instead of the pharmacy?

de Pauw BE, Donnelly JP.

Clin Infect Dis. 2009 Apr 15;48(8):1052-4. No abstract available. PMID: 19281329 [PubMed - indexed for MEDLINE]Related articles

Present situation in the treatment of invasive fungal infection.

de Pauw BE, Picazo JJ.

Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S167-71. Review.PMID: 19013343 [PubMed - indexed for MEDLINE]Related articles

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BE.

Clin Infect Dis. 2008 Sep 1;47(5):674-83. Review.PMID: 18637757 [PubMed - indexed for MEDLINE]Related articlesFree article

The value of randomized clinical trials for daily clinical practice.

de Pauw BE, Rubin RH.

Transpl Infect Dis. 2007 Sep;9(3):173-4. No abstract available. PMID: 17692066 [PubMed - indexed for MEDLINE]Related articles

Autotransfusion management during and after cardiopulmonary bypass alters fibrin degradation and transfusion requirements.

Wiefferink A, Weerwind PW, van Heerde W, Teerenstra S, Noyez L, de Pauw BE, Brouwer RM.

J Extra Corpor Technol. 2007 Jun;39(2):66-70.PMID: 17672185 [PubMed - indexed for MEDLINE]Related articles

Individualization in the management of fungal disease in the transplant recipient.

de Pauw BE, Rubin RH.

Transpl Infect Dis. 2007 Jun;9(2):87-8. No abstract available. PMID: 17461991 [PubMed - indexed for MEDLINE]Related articles

Comparison of two highly discriminatory molecular fingerprinting assays for analysis of multiple Aspergillus fumigatus isolates from patients with invasive aspergillosis.

de Valk HA, Meis JF, de Pauw BE, Donnelly PJ, Klaassen CH.

J Clin Microbiol. 2007 May;45(5):1415-9. Epub 2007 Mar 21.PMID: 17376887 [PubMed - indexed for MEDLINE]Related articlesFree article

Prophylaxis and aspergillosis--has the principle been proven?

De Pauw BE, Donnelly JP.

N Engl J Med. 2007 Jan 25;356(4):409-11. No abstract available. PMID: 17251538 [PubMed - indexed for MEDLINE]Related articles

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.

Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, Wingard JR, Herbrecht R, Ribaud P, Patterson TF, Troke PF, Denning DW, Bennett JE, de Pauw BE, Rubin RH.

Clin Infect Dis. 2007 Feb 1;44(3):373-9. Epub 2006 Dec 29.PMID: 17205443 [PubMed - indexed for MEDLINE]Related articles

Treatment of malignant haematological diseases: from maximally tolerated to minimally required?

de Pauw BE.

Curr Opin Oncol. 2006 Nov;18(6):648-51. Review. No abstract available. PMID: 16988589 [PubMed - indexed for MEDLINE]Related articles

Increasing fungal infections in the intensive care unit.

De Pauw BE.

Surg Infect (Larchmt). 2006;7 Suppl 2:S93-6. Review.PMID: 16895517 [PubMed - indexed for MEDLINE]Related articles

Microbiologic consequences of new approaches to managing hematologic malignancies.

Blijlevens NM, Donnelly JP, de Pauw BE.

Rev Clin Exp Hematol. 2005 Dec;9(2):E2. Review.PMID: 16864116 [PubMed - indexed for MEDLINE]Related articles

Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study.

de Pauw BE, Sable CA, Walsh TJ, Lupinacci RJ, Bourque MR, Wise BA, Nguyen BY, DiNubile MJ, Teppler H.

Transpl Infect Dis. 2006 Mar;8(1):31-7.PMID: 16623818 [PubMed - indexed for MEDLINE]Related articles

Empiric versus preemptive therapy in the management of febrile neutropenia in the patient being treated for hematologic malignancy.

de Pauw BE, Rubin RH.

Transpl Infect Dis. 2006 Mar;8(1):1-2. No abstract available. PMID: 16623814 [PubMed - indexed for MEDLINE]Related articles

Evolution in the treatment of hematologic malignancies.

de Pauw BE.

Curr Opin Oncol. 2005 Nov;17(6):593-6. Review. No abstract available. PMID: 16224239 [PubMed - indexed for MEDLINE]Related articles

Between over- and undertreatment of invasive fungal disease.

de Pauw BE.

Clin Infect Dis. 2005 Nov 1;41(9):1251-3. Epub 2005 Sep 29. No abstract available. PMID: 16206098 [PubMed - indexed for MEDLINE]Related articles

Voriconazole (Pfizer ltd).

Verweij PE, de Pauw BE, Meis JF.

IDrugs. 1999 Sep;2(9):925-37.PMID: 16121307 [PubMed]Related articles

Should the consensus guidelines' specific criteria for the diagnosis of invasive fungal infection be changed?

de Pauw BE, Patterson TF.

Clin Infect Dis. 2005 Sep 15;41 Suppl 6:S377-80.PMID: 16108002 [PubMed - indexed for MEDLINE]Related articles

[Improved diagnostics in invasive aspergillosis and systematic monitoring in patients at high risk of infection]

Verweij PE, Donnelly JP, van Die CE, Blijlevens NM, Kullberg BJ, de Pauw BE.

Ned Tijdschr Geneeskd. 2005 Mar 12;149(11):561-7. Review. Dutch. PMID: 15799638 [PubMed - indexed for MEDLINE]Related articles

Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant.

Blijlevens NM, Donnelly JP, de Pauw BE.

Bone Marrow Transplant. 2005 Apr;35(7):707-11.PMID: 15785771 [PubMed - indexed for MEDLINE]Related articles

Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.

Lutgens LC, Blijlevens NM, Deutz NE, Donnelly JP, Lambin P, de Pauw BE.

Cancer. 2005 Jan 1;103(1):191-9.PMID: 15573372 [PubMed - indexed for MEDLINE]Related articlesFree article

An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.

Oude Lashof AM, De Bock R, Herbrecht R, de Pauw BE, Krcmery V, Aoun M, Akova M, Cohen J, Siffnerová H, Egyed M, Ellis M, Marinus A, Sylvester R, Kullberg BJ; EORTC Invasive Fungal Infections Group.

Eur J Cancer. 2004 Jun;40(9):1314-9.PMID: 15177489 [PubMed - indexed for MEDLINE]Related articles

Measuring mucosal damage induced by cytotoxic therapy.

Blijlevens NM, van't Land B, Donnelly JP, M'Rabet L, de Pauw BE.

Support Care Cancer. 2004 Apr;12(4):227-33. Epub 2004 Jan 30.PMID: 14752625 [PubMed - indexed for MEDLINE]Related articles

Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.

Donnelly JP, De Pauw BE.

Clin Microbiol Infect. 2004 Mar;10 Suppl 1:107-17. Review.PMID: 14748807 [PubMed - indexed for MEDLINE]Related articles

Feasibility of a new in vitro approach to evaluate cellular damage following co-infusion of red blood cell concentrates and intravenous drug solutions.

van den Bos A, Wissink WM, Schattenberg AV, Werre JM, de Pauw BE.

Clin Lab Haematol. 2003 Jun;25(3):173-8.PMID: 12755794 [PubMed - indexed for MEDLINE]Related articlesFree article

Aspergillus galactomannan antigen levels in allogeneic haematopoietic stem cell transplant recipients given total parenteral nutrition.

Blijlevens NM, Donnelly JP, Meis JF, Verweij PE, de Pauw BE.

Transpl Infect Dis. 2002 Jun;4(2):64-5.PMID: 12220241 [PubMed - indexed for MEDLINE]Related articles

Impaired gut function as risk factor for invasive candidiasis in neutropenic patients.

Blijlevens NM, Donnelly JP, de Pauw BE.

Br J Haematol. 2002 May;117(2):259-64. Review. No abstract available. PMID: 11972507 [PubMed - indexed for MEDLINE]Related articles

Treatment of documented and suspected neutropenia-associated invasive fungal infections.

De Pauw BE.

J Chemother. 2001 Nov;13 Spec No 1(1):181-92. Review.PMID: 11936364 [PubMed - indexed for MEDLINE]Related articles

Achievements and goals of the EORTC Invasive Fungal Infections Group. European Organisation for Research and Treatment of Cancer.

de Pauw BE, Herbrecht R, Meunier F; EORTC Invasive Fungal Infections Group.

Eur J Cancer. 2002 Mar;38 Suppl 4:S88-93.PMID: 11858972 [PubMed - indexed for MEDLINE]Related articles

Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy.

Blijlevens NM, Donnelly JP, de Pauw BE.

Clin Microbiol Infect. 2001;7 Suppl 4:47-52. Review.PMID: 11688534 [PubMed - indexed for MEDLINE]Related articles

Advances in the management of invasive fungal infections in organ transplant recipients: step by step.

de Pauw BE.

Transpl Infect Dis. 2000 Jun;2(2):48-50. Review. No abstract available. PMID: 11429012 [PubMed - indexed for MEDLINE]Related articles

Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses.

Rex JH, Walsh TJ, Nettleman M, Anaissie EJ, Bennett JE, Bow EJ, Carillo-Munoz AJ, Chavanet P, Cloud GA, Denning DW, de Pauw BE, Edwards Jr JE, Hiemenz JW, Kauffman CA, Lopez-Berestein G, Martino P, Sobel JD, Stevens DA, Sylvester R, Tollemar J, Viscoli C, Viviani MA, Wu T.

Clin Infect Dis. 2001 Jul 1;33(1):95-106. Epub 2001 Jun 5.PMID: 11389501 [PubMed - indexed for MEDLINE]Related articles

Reliability of clinical research on invasive fungal infections: a systematic review of the literature.

Ascioglu S, de Pauw BE, Donnelly JP, Collette L.

Med Mycol. 2001 Feb;39(1):35-40. Review.PMID: 11270406 [PubMed - indexed for MEDLINE]Related articles

Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation.

Blijlevens NM, Donnelly JP, Meis JF, De Keizer MH, De Pauw BE.

Clin Diagn Lab Immunol. 2000 Nov;7(6):889-92.PMID: 11063493 [PubMed - indexed for MEDLINE]Related articlesFree article

New antifungal agents and preparations.

De Pauw BE.

Int J Antimicrob Agents. 2000 Oct;16(2):147-50. Review.PMID: 11053798 [PubMed - indexed for MEDLINE]Related articles

[Leukocyte depletion of blood products: a requirement for improvement of quality and safety]

De Pauw BE, Van den Bos A.

Ned Tijdschr Geneeskd. 2000 Sep 2;144(36):1754-6. Dutch. No abstract available. PMID: 10992905 [PubMed - indexed for MEDLINE]Related articles

Prophylaxis and treatment of fungal infections associated with haematological malignancies.

Ascioglu S, de Pauw BE, Meis JF.

Int J Antimicrob Agents. 2000 Aug;15(3):159-68. Review.PMID: 10926437 [PubMed - indexed for MEDLINE]Related articles

Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.

Blijlevens NM, Donnelly JP, De Pauw BE.

Bone Marrow Transplant. 2000 Jun;25(12):1269-78. Review.PMID: 10871732 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of fungal infections in surgical patients using conventional antifungals.

De Pauw BE, Donnelly JP, Kullberg BJ.

J Chemother. 1999 Dec;11(6):494-503. Review.PMID: 10678791 [PubMed - indexed for MEDLINE]Related articles

Therapy of invasive fungal infections.

Kullberg BJ, de Pauw BE.

Neth J Med. 1999 Sep;55(3):118-27. Review.PMID: 10509070 [PubMed - indexed for MEDLINE]Related articles

The challenge of invasive fungal infection.

de Pauw BE, Meunier F.

Chemotherapy. 1999 Jun;45 Suppl 1:1-14. Review.PMID: 10394016 [PubMed - indexed for MEDLINE]Related articles

High-dose fluconazole therapy in patients with severe fungal infections.

Voss A, de Pauw BE.

Eur J Clin Microbiol Infect Dis. 1999 Mar;18(3):165-74. Review. No abstract available. PMID: 10357048 [PubMed - indexed for MEDLINE]Related articles

Invasive aspergillosis caused by Aspergillus ustus: case report and review.

Verweij PE, van den Bergh MF, Rath PM, de Pauw BE, Voss A, Meis JF.

J Clin Microbiol. 1999 May;37(5):1606-9. Review.PMID: 10203536 [PubMed - indexed for MEDLINE]Related articlesFree article

Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation.

Meis JF, Ruhnke M, De Pauw BE, Odds FC, Siegert W, Verweij PE.

Emerg Infect Dis. 1999 Jan-Feb;5(1):150-3.PMID: 10081684 [PubMed - indexed for MEDLINE]Related articlesFree article

Evolution of the clinical manifestations of infection during the course of febrile neutropenia in patients with malignancy.

Dompeling EC, Donnelly JP, Raemaekers JM, Deresinski SC, Feld R, De Pauw BE.

Infection. 1998 Nov-Dec;26(6):349-54.PMID: 9861558 [PubMed - indexed for MEDLINE]Related articles

[Perplexing acute or chronic somatic or psychiatric symptoms: possibly due to porphyria]

Schattenberg AV, de Pauw BE.

Ned Tijdschr Geneeskd. 1998 Aug 8;142(32):1801-4. Review. Dutch. PMID: 9856148 [PubMed - indexed for MEDLINE]Related articles

Host impairments in patients with neoplastic diseases.

De Pauw BE, Donnelly JP, Kullberg BJ.

Cancer Treat Res. 1998;96:1-32. Review. No abstract available. PMID: 9711394 [PubMed - indexed for MEDLINE]Related articles

Progress in fighting systemic fungal infections in haematological neoplasia.

De Pauw BE, Meis JF.

Support Care Cancer. 1998 Jan;6(1):31-8. Review.PMID: 9458534 [PubMed - indexed for MEDLINE]Related articles

Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin's lymphoma.

Mandigers CM, Raemaekers JM, Schattenberg AV, Roovers EA, Bogman MJ, van der Maazen RW, De Pauw BE, De Witte T.

Br J Haematol. 1998 Jan;100(1):198-206.PMID: 9450812 [PubMed - indexed for MEDLINE]Related articles

Two strategies for managing invasive aspergillosis: a decision analysis.

Severens JL, Donnelly JP, Meis JF, De Vries Robbé PF, De Pauw BE, Verweij PE.

Clin Infect Dis. 1997 Nov;25(5):1148-54.PMID: 9402374 [PubMed - indexed for MEDLINE]Related articles